Detalles de la búsqueda
1.
Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).
Z Gastroenterol
; 61(5): 489-503, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839795
2.
[Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)]. / Intersektorales Management von Patienten mit unklarer Leberwerterhöhung und nichtalkoholischer Fettlebererkrankung (NAFLD).
Z Gastroenterol
; 61(8): 1028-1036, 2023 Aug.
Artículo
en Alemán
| MEDLINE | ID: mdl-36791784
3.
[Frequency of diagnosed non-alcololic fatty liver disease (NAFLD) in the German population - An analysis based on health insurance data]. / Die Häufigkeit von diagnostizierten Fettlebererkrankungen (NAFLD) in der deutschen Bevölkerung Eine Analyse auf der Basis von GKV-Routinedaten.
Z Gastroenterol
; 59(8): 851-858, 2021 Aug.
Artículo
en Alemán
| MEDLINE | ID: mdl-33757144
4.
Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies.
BMC Infect Dis
; 19(1): 1019, 2019 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791253
5.
Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective.
Clinicoecon Outcomes Res
; 16: 483-492, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38859889
6.
Is there a place for sigmoidoscopy in colorectal cancer screening? A systematic review and critical appraisal of cost-effectiveness models.
PLoS One
; 18(8): e0290353, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594967
7.
Lifestyle interventions for patients with non-alcoholic steato-hepatitis-Design, rationale and protocol of the study "target group-specific optimisation of lifestyle interventions for behavior change in non-alcoholic steato-hepatitis (OPTI-NASH)".
PLoS One
; 18(7): e0288905, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37498941
8.
[Prevalence of metabolic syndrome : Analysis based on routine statutory health insurance data]. / Prävalenz des metabolischen Syndroms : Eine Analyse auf Basis von Routinedaten einer gesetzlichen Krankenversicherung.
Inn Med (Heidelb)
; 64(5): 482-489, 2023 May.
Artículo
en Alemán
| MEDLINE | ID: mdl-37058154
9.
Non-Invasive Reliable Methods to Objectify the Positive Influence of Hepatitis C Virus Treatment on Liver Stiffness.
Gastroenterology Res
; 14(1): 31-40, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33737997
10.
[Acute exacerbation of reactivated chronic hepatitis-b after stopping antiviral medication followed by loss of HBsAg]. / Akute Exazerbation einer reaktivierten chronischen Hepatitis B nach Absetzen der antiviralen Therapie mit nachfolgendem Verlust des HBsAg.
Dtsch Med Wochenschr
; 145(8): 552-554, 2020 04.
Artículo
en Alemán
| MEDLINE | ID: mdl-32294781
11.
Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.
Pharmacoeconomics
; 27(4): 341-54, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19485429
12.
Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry.
Eur J Gastroenterol Hepatol
; 31(2): 230-240, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30325794
13.
[Constipation in patients with diabetes mellitus]. / Wenn die Polyneuropathie den Darm lahm legt.
MMW Fortschr Med
; 149(44): 39-42, 2007 Nov 01.
Artículo
en Alemán
| MEDLINE | ID: mdl-18078169
14.
Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany.
PLoS One
; 12(1): e0169401, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28046099
15.
Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
Clin Cancer Res
; 11(18): 6550-7, 2005 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16166432
16.
Ultrasound Elastography Used for Preventive Non-Invasive Screening in Early Detection of Liver Fibrosis.
J Clin Med Res
; 8(9): 650-5, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27540438
17.
High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.
Eur J Gastroenterol Hepatol
; 28(11): 1246-52, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27439034
18.
Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.
PLoS One
; 11(7): e0159976, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27467772
19.
Polymorphisms in the IL-12B gene and outcome of HCV infection.
J Interferon Cytokine Res
; 25(5): 271-6, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15871664
20.
Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany.
Eur J Health Econ
; 6(2): 112-23, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15902546